🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1, open-label, fixed-sequence, 2-part DDI study. Subjects w...
Status
Completed
Location
Site 1
Start Date
2023-01-03
Trial ID
NCT05657613
This study has two parts. Part 1 will evaluate how pexidartinib affects th...
Status
Completed
Location
HonorHealth
Start Date
2018-02-26
Trial ID
NCT03291288
Treatments Being Tested
This study will assess safety, tolerability and pharmacokinetic (PK) of VH3...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2024-08-02
Trial ID
NCT06533280
This is a phase I, open-label, fixed sequence design, drug-drug-interaction...
Status
Completed
Location
CTC Clinical Trials Consultants AB
Start Date
2022-11-27
Trial ID
NCT05633147
This study will assess the potential for clinical drug-drug interactions be...
Status
Completed
Location
Covance Clinical Research Unit (CRU) Inc.
Start Date
2019-06-14
Trial ID
NCT04008186
The purpose of this study is to determine the safety of an extracellular si...
Status
Completed
Location
Georgetown University Medical Center
Start Date
2016-09-29
Trial ID
NCT02857270
Treatments Being Tested
This is an investigator-and-subject blind, phase 1 study to characterize th...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2015-05
Trial ID
NCT02440100
Treatments Being Tested
This trial will consist of two parts: Part 1 and Part 2. Part 1 will enroll...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-04-10
Trial ID
NCT03140527
The purpose of this study is to evaluate the safety and tolerability and ph...
Status
Terminated
Location
Clinical Pharmacology Unit
Start Date
2017-05-17
Trial ID
NCT03139500
Treatments Being Tested